(r)-3-hydroxybutanoic acid

(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid

MeSH term MeSH ID Detail
Fatty Liver D005234 48 associated lipids
Ketosis D007662 13 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Intestinal Diseases D007410 6 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Coronary Disease D003327 70 associated lipids
Liver Diseases D008107 31 associated lipids
Corneal Diseases D003316 13 associated lipids
Per page 10 20 50 100 | Total 185

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (r)-3-hydroxybutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 2707
Authors Title Published Journal PubMed Link
Laker ME and Mayes PA Regulation of 3-hydroxybutyrate formation and secretion of very-low-density-lipoprotein triacylglycerol by perfused livers from fed and starved rats. 1982 Biochem. J. pmid:7150254
Pickup JC et al. Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. 1982 Diabetologia pmid:7042428
Fallucca F et al. Effects of somatostatin on established induced ketosis. 1982 Horm. Metab. Res. pmid:6129185
Waldhäusl WK et al. Insulin production rate in normal man as an estimate for calibration of continuous intravenous insulin infusion in insulin-dependent diabetic patients. 1982 Jan-Feb Diabetes Care pmid:6754299
MacGillivray MH et al. Hormone and metabolic profiles in children and adolescents with type I diabetes mellitus. 1982 May-Jun Diabetes Care pmid:6821306
Ianovich VG et al. [Peculiarities of the metabolism of beta-oxybutyric acid in liver and skeletal muscles of piglets]. 1982 Sep-Oct Ukr. Biokhim. Zh. pmid:7135511
Calabrese G et al. Continuous subcutaneous insulin infusion treatment in insulin-dependent diabetic patients: a comparison with conventional optimized treatment in a long-term study. 1982 Sep-Oct Diabetes Care pmid:7188333
Kauppinen K Correlation of whole blood concentrations of acetoacetate, beta-hydroxybutyrate, glucose and milk yield in dairy cows as studied under field conditions. 1983 Acta Vet. Scand. pmid:6687103
White NJ et al. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. 1983 N. Engl. J. Med. pmid:6343877
Kim CS et al. Effect of increasing carbon chain length on organic acid transport by the choroid plexus: a potential factor in Reye's syndrome. 1983 Brain Res. pmid:6402269